Skip to main content
. 2023 Jul 30;11(8):2149. doi: 10.3390/biomedicines11082149

Table 2.

Area under the ROC for the prediction of mortality at 28 days and 90 days.

Analyses
Univariate Multivariate
Biomarker or Clinical Score Patients (N) AUROC OR IQR (95% CI) OR IQR (95% CI)
M28d MR-proADM 284 0.57 [0.45–0.69] 1.08 [0.94–1.24] 1.13 [0.82–1.56]
PCT 274 0.47 [0.35–0.59] 0.99 [0.98–1.01] 0.99 [0.97–1.02]
CRP 237 0.49 [0.36–0.62] 1.00 [0.99–1.01] 1.01 [0.98–1.04]
Lactate 229 0.67 [0.55–0.79] 1.13 [0.95–1.34] 0.85 [0.49–1.49]
SOFA 284 0.63 [0.52–0.73] 1.43 [1.03–1.97] 1.63 [0.69–3.84]
M90d MR-proADM 284 0.59 [0.49–0.68] 1.08 [0.96–1.21] 0.93 [0.72–1.20]
PCT 274 0.44 [0.34–0.54] 1.00 [0.99–1.00] 0.99 [0.97–1.01]
CRP 237 0.54 [0.43–0.65] 1.00 [0.99–1.01] 1.00 [0.98–1.03]
Lactate 229 0.66 [0.55–0.77] 1.25 [1.07–1.46] 1.50 [0.90–2.50]
SOFA 284 0.62 [0.54–0.71] 1.40 [1.08–1.81] 1.31 [0.70–2.43]

Abbreviations: AUROC, area under the ROC; CI, confidence interval; OR, odds ratio; IQR, interquartile range; M28d, 28-day mortality; M90d, 90-day mortality. Multivariate analyses show the OR for predictive ability of every biomarker when combined between themselves and the inclusion of other variables: age, SOFA, APACHE II, and nosocomial infection.